flag
Insights into Essex Partnerships deployment of OxevisionDownload
Download
arrow right
cross
09
March
2021
Editorial note:
These articles may pre-date our recent FDA clearance, Some references may not accurately reflect this.
Editorial note:
This article may refer to our solution as the "Digital Care Assistant", which we recently renamed to "Oxevision".

Oxehealth Secure Investment to Fund Commercial Expansion

Oxehealth Secure Investment to Fund Commercial Expansion

Oxehealth have announced today that the company has secured financial commitments totalling £10m, which will be delivered in two rounds across 2021 and 2022. The rounds have been underwritten by existing shareholders and will be used to fund the commercial expansion of Oxevision, a vision-based patient monitoring and management platform.

Oxehealth Chief Executive Hugh Lloyd-Jukes said, “Oxehealth more than doubled annual recurring revenue in 2020.  We are helping clinicians to deliver safer, higher quality and more efficient care in sectors which will be critical to societies’ recovery from COVID-19: mental health, ageing and step-down care. I’m delighted that this commitment gives us the funds we require to grow the business in support of clinicians in Europe and beyond over the next 2-3 years.”

Chairman of the Board, James Ede-Golightly commented “We are very pleased to have the support of our shareholders to accelerate the roll out of Oxevision into our existing markets and into new care settings around the world.”

 

Get in touch
arrow right